204 related articles for article (PubMed ID: 31107559)
1. First-in-human implantation of a mid-field powered neurostimulator at the sacral nerve: Results from an acute study.
van Kerrebroeck PEVA; Reekmans M; van Koeveringe GA; Yeh AJ; Fayram TA; Sharan AD; Comiter CV
Neurourol Urodyn; 2019 Aug; 38(6):1669-1675. PubMed ID: 31107559
[TBL] [Abstract][Full Text] [Related]
2. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
[TBL] [Abstract][Full Text] [Related]
3. Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation?
Peters KM; Killinger KA; Boura JA
Neurourol Urodyn; 2011 Nov; 30(8):1489-92. PubMed ID: 21674596
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.
Myer ENB; Petrikovets A; Slocum PD; Lee TG; Carter-Brooks CM; Noor N; Carlos DM; Wu E; Van Eck K; Fashokun TB; Yurteri-Kaplan L; Chen CCG
Am J Obstet Gynecol; 2018 Jul; 219(1):78.e1-78.e9. PubMed ID: 29630890
[TBL] [Abstract][Full Text] [Related]
5. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
6. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
Girtner F; Burger M; Mayr R
Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
[TBL] [Abstract][Full Text] [Related]
7. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation.
Siegel S; Noblett K; Mangel J; Bennett J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Zylstra S; Kan F; Berg KC
J Urol; 2018 Jan; 199(1):229-236. PubMed ID: 28709886
[TBL] [Abstract][Full Text] [Related]
8. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
[TBL] [Abstract][Full Text] [Related]
9. Specific Changes in Brain Activity during Urgency in Women with Overactive Bladder after Successful Sacral Neuromodulation: A Functional Magnetic Resonance Imaging Study.
Weissbart SJ; Bhavsar R; Rao H; Wein AJ; Detre JA; Arya LA; Smith AL
J Urol; 2018 Aug; 200(2):382-388. PubMed ID: 29630979
[TBL] [Abstract][Full Text] [Related]
10. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of sacral neuromodulation with the tined lead procedure.
Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
[TBL] [Abstract][Full Text] [Related]
12. Neural pathway of bellows response during SNM treatment revisited: Conclusive evidence for direct efferent motor response.
Vaganée D; Voorham J; Panicker JN; Fransen E; Voorham-van der Zalm P; Van de Borne S; De Wachter S
Neurourol Urodyn; 2020 Jun; 39(5):1576-1583. PubMed ID: 32484961
[TBL] [Abstract][Full Text] [Related]
13. Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation.
Siegel S; Noblett K; Mangel J; Griebling TL; Sutherland SE; Bird ET; Comiter C; Culkin D; Bennett J; Zylstra S; Kan F; Thiery E
Urology; 2016 Aug; 94():57-63. PubMed ID: 27131966
[TBL] [Abstract][Full Text] [Related]
14. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-year experience.
Groen LA; Hoebeke P; Loret N; Van Praet C; Van Laecke E; Ann R; Vande Walle J; Everaert K
J Urol; 2012 Oct; 188(4):1313-7. PubMed ID: 22902022
[TBL] [Abstract][Full Text] [Related]
15. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints.
Heesakkers JPFA; Digesu GA; van Breda J; Van Kerrebroeck P; Elneil S
Neurourol Urodyn; 2018 Mar; 37(3):1060-1067. PubMed ID: 28892221
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: A systematic review.
Siddiqui NY; Wu JM; Amundsen CL
Neurourol Urodyn; 2010; 29 Suppl 1():S18-23. PubMed ID: 20419795
[TBL] [Abstract][Full Text] [Related]
17. Sacral nerve stimulation for refractory overactive bladder in the elderly population.
White WM; Mobley JD; Doggweiler R; Dobmeyer-Dittrich C; Klein FA
J Urol; 2009 Oct; 182(4):1449-52. PubMed ID: 19683295
[TBL] [Abstract][Full Text] [Related]
18. Sacral Neuromodulation for Genitourinary Problems.
Banakhar M; Hassouna M
Prog Neurol Surg; 2015; 29():192-9. PubMed ID: 26394134
[TBL] [Abstract][Full Text] [Related]
19. Detailed analysis of adverse events and surgical interventions in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients.
Noblett K; Benson K; Kreder K
Neurourol Urodyn; 2017 Apr; 36(4):1136-1139. PubMed ID: 27491027
[TBL] [Abstract][Full Text] [Related]
20. Urethral instability and sacral nerve stimulation-a better parameter to predict efficacy?
Groenendijk PM; Heesakkers JP; Lycklama A Nijeholt AA
J Urol; 2007 Aug; 178(2):568-72; discussion 572. PubMed ID: 17570438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]